[1] Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 CD25 regulatory T cells[J]. Nat Immuno1, 2003, 4(4):330-336.
[2] Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4 CD25 T regulatory cells[J]. Nat Immunol, 2003, 4(4):337-342.
[3] Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3[J]. Science, 2003, 299(5609):1057-1061.
[4] Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases[J]. J Immunol, 1995, 155(3):1151-1164.
[5] Shevach EM, McHugh RS, Piccirillo CA, Thornton AM. Control of T-cell activation by CD4 CD25 suppressor T cells[J]. Immunol Rev, 2001, 182:58-67.
[6] Sakaguchi S, Sakaguchi N, Shimizu J, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kunigasu Y, Nomuk T, Toda M, Takahashi T. Immunologic tolerance maintained by CD25 CD4 regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance[J]. Immunol Rev, 2001, 182:18-32.
[7] Thornton AM, Shevach EM. Suppressor effector function of CD25 CD4 immunoregulatory T cells is antigen nonspecific[J]. J Immunol, 2000, 164(1):183-190.
[8] Suhubert LA, Jeffery E, Zhang Y, Kamsdell F, Zieqler SF. Scurfin (FOXP3) acts as a repressor of transcription and regulates T cell activation[J]. J Biol Chem, 2001, 276(40):37672-37679.
[9] Brunkow ME, Jeffery EW, Hjerrild KA, Ramsdell F, Zieqler SF. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse[J]. Nat Genet, 2001, 27(1):68-73.
[10] Chatila TA, Blaeser F, Ho N, Lederman HM, Voulqaropoulos L, Helms C, Bowcock AM. JM2 encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome[J]. J Clin invest, 2000,106(12):R75-81.
[11] Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease[J]. Nat Immunol, 2005, 6(4):353-360.
[12] Jo EK, Park JK, Dockrell HM. Dynamics of cytokine generation in patients with active pulmonary tuberculosis[J]. Curr Opin Infect Dis, 2003, 16 (3):205-210.
[13] Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow OY, Ban B, Benaqiano M, Diallo A, Manetti R, Manneh K, Gustafson P, Bennett S, D’Elios MM, McAdam K, Del Prete G. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo[J]. Eur J Immunol, 2002, 32 (6):1605-1613.
|